Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDiploma Regulatory News (DPLM)

Share Price Information for Diploma (DPLM)

Share Price is delayed by 15 minutes
Get Live Data
7,130.00    80.00 (1.13%)
Bid:
7,110.00
Ask:
7,120.00
Spread: 10.00 (0.141%)
Market Cap: £9.56b
DPLM Live PriceLast checked at - London Stock Exchange

Intraday Diploma Share Chart

Acquisition

13 Mar 2015 07:00

RNS Number : 3303H
Diploma PLC
13 March 2015
Β 

Β 

DIPLOMAΒ PLC

12 CHARTERHOUSE SQUARE, LONDON EC1M 6AX

TELEPHONE: +44 (0)20 7549 5700

FACSIMILE: +44 (0)20 7549 5715

Β 

FOR IMMEDIATE RELEASE

Β 

13 March 2015

Β 

Β 

DIPLOMA PLC

Β 

DIPLOMA ACQUIRES KUBO GROUP FOR A MAXIMUM

NET CASH CONSIDERATION OF Β£22.5m (CHF32.9m)

Β 

Diploma PLC, the international group of businesses supplying specialised technical products and services, is pleased to announce the acquisition of 100% of Rutin AG, the Swiss non-trading holding company of the Kubo Group ("Kubo") of companies based in Switzerland and Austria.

Β 

Kubo is a long established and leading supplier of seals, O-Rings, gaskets and moulded rubber parts to a large and diverse base of industrial customers in Switzerland and Austria. Kubo's principal location is in Effretikon, near Zurich in Switzerland, comprising a modern building with a combination of warehouse, manufacturing and office facilities. Kubo employs ca. 100 people, of which ca. 15 are based in the facility in Linz, Austria.

Β 

Kubo serves both the Industrial OEM and Aftermarket sectors, typically in applications that require a high degree of technical knowledge and support. The business specialises in high value products that address harsh environments or complex applications. Kubo also retains exclusive distribution rights in Switzerland and Austria for certain large international manufacturers of sealing products and O-Rings.

Β 

Prior to acquisition, Kubo was privately owned by Dr Thomas Raible, its Chief Executive Officer ("CEO") and majority shareholder, together with members of the Gebert family (Cyrill, Manuel and Rebecca, represented by Christa Gebert) and Dr Georges Bindschedler. Of the Sellers, only Dr Raible had an active management role in Kubo and he will remain as the CEO of Kubo until 30 June 2015 to ensure a smooth management transition.

Β 

Profit before tax for Kubo in the year ended 31 December 2014 was CHF4.9m (Β£3.4m) on revenues of CHF32.4m (Β£22.2m); gross assets at 31 December 2014 were CHF36.1m (Β£24.7m).

Β 

The cash consideration before acquisition costs is CHF39.9m (Β£27.3m), which will be met from the Group's existing cash resources and revolving bank credit facility. At completion, net assets are expected to be approximately CHF30.3m (Β£20.7m), including net cash of approximately CHF7.0m (Β£4.8m) and goodwill of CHF11.6m (Β£7.9m). Also included in the net assets is the freehold facility in Effretikon, with a net book value of CHF7.0m (Β£4.8m) and a market value of at least CHF10.0m (Β£6.8m).

Β 

This transaction will be immediately earnings enhancing to the Company and will be reported as part of the Seals sector activities.

Β 

Β 

Β 

Bruce Thompson, Chief Executive of Diploma PLC said:

Β 

"The acquisition of Kubo Group fits very well with Diploma's strategy in Seals of building a stronger European business in the supply of seals, gaskets and related products to both the Industrial OEM and Aftermarket sectors. The acquisition will also open up opportunities for cross selling of products with Diploma's other Seals businesses, including access to Kubo's high precision, manufactured parts."

Β 

Β 

Β 

Diploma PLC -

+44 (0)20 7549 5700

Bruce Thompson, Chief Executive Officer

Nigel Lingwood, Group Finance Director

Tulchan Communications -

+44 (0)20 7353 4200

David Allchurch

Martin Robinson

Β 

Β 

Β 

NOTE TO EDITORS:

Β 

Diploma PLC is an international group of businesses supplying specialised technical products and services to the Life Sciences, Seals and Controls industries.

Β 

Diploma's businesses are focussed on supplying essential products and services which are funded by the customers' operating rather than their capital budgets, providing recurring income and stable revenue growth.

Β 

Our businesses design their individual business models to closely meet the requirements of their customers, offering a blend of high quality customer service, deep technical support and value adding activities. By supplying essential solutions, not just products, we build strong long term relationships with our customers and suppliers, which support attractive and sustainable margins.

Β 

Finally we encourage an entrepreneurial culture in our businesses through our decentralised management structure. We want our managers to feel that they have the freedom to run their own businesses, while being able to draw on the support and resources of a larger group. These essential values ensure that decisions are made close to the customer and that the businesses are agile and responsive to changes in the market and the competitive environment.

Β 

The Group employs ca. 1,300 employees and its principal operating businesses are located in the UK, Germany, US, Canada and Australia.

Β 

Over the last five years, the Group has grown adjusted earnings per share at an average of 20% p.a. through a combination of organic growth and acquisitions. Diploma is a member of the FTSE 250 with a market capitalisation of ca. Β£900m.

Β 

Β 

Further information on Diploma PLC, together with a copy of this Announcement, is available at www.diplomaplc.com

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
ACQPKBDBABKDBND
Date   Source Headline
1st Jun 20264:00 pmRNSAppointment of Non-Executive Director
21st May 20265:01 pmRNSDirector/PDMR Shareholding
19th May 20267:00 amRNSHalf Year Results
20th Apr 20265:33 pmRNSHolding(s) in Company
9th Apr 20261:16 pmRNSHolding(s) in Company
23rd Mar 20263:02 pmRNSDirector/PDMR Shareholding
18th Mar 20267:00 amRNSSignificant upgrade to FY26 guidance
27th Feb 20261:45 pmRNSAppointment of Non-Executive Director
27th Jan 20264:06 pmRNSHolding(s) in Company
16th Jan 20263:05 pmRNSDirector/PDMR Shareholding
15th Jan 202610:30 amRNSDirector/PDMR Shareholding
14th Jan 20263:53 pmRNSResult of AGM
14th Jan 20267:00 amRNSQ1 2026 Trading Update
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
22nd Dec 20257:00 amRNSDirector/PDMR Shareholding
19th Dec 20251:33 pmRNSHolding(s) in Company
19th Dec 20251:33 pmRNSHolding(s) in Company
18th Dec 202510:52 amRNSHolding(s) in Company
17th Dec 20257:00 amRNSChief Financial Officer appointment
8th Dec 20257:00 amRNSAnnual Financial Report & Notice of AGM
1st Dec 20257:00 amRNSTotal Voting Rights
26th Nov 20257:00 amRNSDirector/PDMR Grant of LTIP Awards
19th Nov 20252:17 pmRNSDirector/PDMR Shareholding
19th Nov 20257:00 amRNSDirector/PDMR Shareholding
18th Nov 20257:00 amRNSPreliminary Results
13th Nov 20257:00 amRNSIssue of Shares & Total Voting Rights
7th Oct 20257:00 amRNSDirector Declaration
2nd Oct 20252:41 pmRNSHolding(s) in Company
14th Aug 20257:00 amRNSChief Financial Officer update
17th Jul 20257:00 amRNSQ3 Trading Update
2nd Jul 20259:49 amRNSHolding(s) in Company
20th Jun 20259:50 amRNSHolding(s) in Company
9th Jun 202512:50 pmRNSHolding(s) in Company
28th May 20259:27 amRNSHolding(s) in Company
21st May 20254:07 pmRNSDirector/PDMR Shareholding
20th May 20257:00 amRNSHalf-year Report
19th May 202511:02 amRNSHolding(s) in Company
19th May 202510:57 amRNSHolding(s) in Company
9th May 20254:24 pmRNSHolding(s) in Company
6th May 20259:32 amRNSHolding(s) in Company
11th Apr 20253:44 pmRNSHolding(s) in Company
3rd Apr 20257:03 amRNSDirector Declaration
25th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20259:36 amRNSHolding(s) in Company
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
24th Mar 20257:00 amRNSDirector/PDMR Shareholding
18th Mar 20259:54 amRNSHolding(s) in Company
3rd Mar 202510:15 amRNSDirector Declaration - External Appointment
25th Feb 20257:00 amRNSHolding(s) in Company
14th Feb 20253:20 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.